Clinical Trial Update: PEFCATII Expanded Safety and Feasibility Study of the FARAPULSE Endocardial Multi Ablation System to Treat Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial reported completion and results of an expanded safety and feasibility study for the FARAPULSE endocardial multi-ablational system in treating par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• FARAPULSE Endocardial Multi Ablation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2022-05-04